Predictors of severe tricuspid regurgitation in patients with permanent pacemaker or automatic implantable cardioverter-defibrillator leads

Texas Heart Institute Journal

Volumn 40, Issue 5, 2013, Pages 529-533

  Najib, Mohammad Q ^a   Vittala, Satya S ^a   Challa, Suresh ^a   Raizada, Amol ^a   Tondato, Fernando J ^a   Lee, Howard R ^a   Chaliki, Hari P ^a  

^a MAYO CLINIC   (United States)

Author keywords

Artificial adverse effects; Atrial fibrillation complications; Cardiac pacing; Defibrillators; Disease progression; Echocardiography; Electrodes; Implantable adverse effects; Implanted adverse effects; Pacemaker; Right diagnosis etiology; Risk factors; Tricuspid valve insufficiency diagnosis etiology; Ventricular dysfunction

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM VOLUME; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE FUNCTION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MALE; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; TRICUSPID ANNULAR DIAMETER; TRICUSPID VALVE REGURGITATION; VERY ELDERLY;

ATRIAL FIBRILLATION/COMPLICATIONS; CARDIAC PACING, ARTIFICIAL/ADVERSE EFFECTS; DEFIBRILLATORS, IMPLANTABLE/ADVERSE EFFECTS; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; ELECTRODES, IMPLANTED/ADVERSE EFFECTS; PACEMAKER, ARTIFICIAL/ADVERSE EFFECTS; RISK FACTORS; TRICUSPID VALVE INSUFFICIENCY/DIAGNOSIS/ETIOLOGY; VENTRICULAR DYSFUNCTION, RIGHT/DIAGNOSIS/ETIOLOGY;

AGED, 80 AND OVER; ATRIAL FIBRILLATION; BLOOD FLOW VELOCITY; DEFIBRILLATORS, IMPLANTABLE; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; FOLLOW-UP STUDIES; HEART ATRIA; HUMANS; MALE; PACEMAKER, ARTIFICIAL; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; STROKE VOLUME; TRICUSPID VALVE; TRICUSPID VALVE INSUFFICIENCY; UNITED STATES;

EID: 84891688169     PISSN: 07302347     EISSN: 15266702     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Lin G, Nishimura RA, Connolly HM, Dearani JA, Sundt TM 3rd, Hayes DL. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverterdefibrillator leads. J Am Coll Cardiol 2005;45(10):1672-5.
2. Najib MQ, Vinales KL, Vittala SS, Challa S, Lee HR, Chaliki HP. Predictors for the development of severe tricuspid regurgitation with anatomically normal valve in patients with atrial fibrillation. Echocardiography 2012;29(2):140-6.
3. Paniagua D, Aldrich HR, Lieberman EH, Lamas GA, Agatston AS. Increased prevalence of significant tricuspid regurgitation in patients with transvenous pacemaker leads. Am J Cardiol 1998;82(9):1130-2, A9.
4. Klutstein M, Balkin J, Butnaru A, Ilan M, Lahad A, Rosenmann D. Tricuspid incompetence following permanent pacemaker implantation. Pacing Clin Electrophysiol 2009;32 Suppl 1:S135-7.
5. Kim JB, Spevack DM, Tunick PA, Bullinga JR, Kronzon I, Chinitz LA, Reynolds HR. The effect of transvenous pacemaker and implantable cardioverter defibrillator lead placement on tricuspid valve function: an observational study. J Am Soc Echocardiogr 2008;21(3):284-7.
6. Zhou X, Otsuji Y, Yoshifuku S, Yuasa T, Zhang H, Takasaki K, et al. Impact of atrial fibrillation on tricuspid and mitral annular dilatation and valvular regurgitation. Circ J 2002;66 (10):913-6.
7. Mutlak D, Aronson D, Lessick J, Reisner SA, Dabbah S, Agmon Y. Functional tricuspid regurgitation in patients with pulmonary hypertension: is pulmonary artery pressure the only determinant of regurgitation severity? Chest 2009;135 (1):115-21.
8. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantif ication Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18(12):1440-63.
9. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010;23(7):685-713.
10. Hannoush H, Fawzy ME, Stefadouros M, Moursi M, Chaudhary MA, Dunn B. Regression of significant tricuspid regurgitation after mitral balloon valvotomy for severe mitral stenosis. Am Heart J 2004;148(5):865-70.
11. Leibowitz DW, Rosenheck S, Pollak A, Geist M, Gilon D. Transvenous pacemaker leads do not worsen tricuspid regurgitation: a prospective echocardiographic study. Cardiology 2000;93(1-2):74-7.
12. de Cock CC, Vinkers M, Van Campe LC, Verhorst PM, Visser CA. Long-term outcome of patients with multiple (> or = 3) noninfected transvenous leads: a clinical and echocardiographic study. Pacing Clin Electrophysiol 2000;23(4 Pt 1): 423-6.
13. Mutlak D, Lessick J, Reisner SA, Aronson D, Dabbah S, Agmon Y. Echocardiography-based spectrum of severe tricuspid regurgitation: the frequency of apparently idiopathic tricuspid regurgitation. J Am Soc Echocardiogr 2007;20(4): 405-8.
14. Shiran A, Sagie A. Tricuspid regurgitation in mitral valve disease: incidence, prognostic implications, mechanism, and management. J Am Coll Cardiol 2009;53(5):401-8.
15. Sakai M, Ohkawa S, Ueda K, Kin H, Watanabe C, Matsushita S, et al. Tricuspid regurgitation induced by transvenous right ventricular pacing: echocardiographic and pathological observations [in Japanese]. J Cardiol 1987;17(2):311-20.
16. Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 2004;43(3): 405-9.